Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Lixte Biotechnology Holdings, Inc. (LIXT) had Return on Investments of -21.65% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-1.94M |
|
-- |
|
-- |
|
$1.99M |
|
$-1.99M |
|
$-0.00M |
|
$-1.99M |
|
$-1.99M |
|
$-1.99M |
|
$-1.99M |
|
$-1.99M |
|
$-1.99M |
|
$-1.99M |
|
$-1.99M |
|
10.89M |
|
10.89M |
|
$-0.18 |
|
$-0.18 |
|
| Balance Sheet Financials | |
$3.41M |
|
-- |
|
$7.46M |
|
$10.87M |
|
$1.22M |
|
-- |
|
$0.46M |
|
$1.69M |
|
$9.18M |
|
$9.18M |
|
$9.18M |
|
11.63M |
|
| Cash Flow Statement Financials | |
$-1.83M |
|
$-0.02M |
|
-- |
|
$5.11M |
|
$3.25M |
|
$-1.86M |
|
$0.14M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.78 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.83M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-21.65% |
|
-21.65% |
|
-18.29% |
|
|
Return on Investments |
-21.65% |
$0.79 |
|
$-0.17 |
|
$-0.17 |
|